Hans Christinger

Hans Christinger is a prominent figure in the biopharmaceutical industry with over 30 years of experience.1 He currently serves as the Chair of NewYorkBIO, an organization that advocates for the life science community in New York State.2

Professional Background

Hans Christinger's career spans various roles in the biopharmaceutical sector:

• Current Position: Chief Business Officer at Neurvati Neurosciences4
• Experience: Business development, drug development, and scientific research1
• Previous Roles: Positions at Ovid Therapeutics, Ophthotech (Iveric), Abbott, and Roche1
• Early Career: Began as a bench scientist at Genentech, authoring 15 peer-reviewed papers in structural biology1

Education

• MBA from Babson College
• Master of Science in Chemistry from San Francisco State University
• Bachelor of Science in Biochemistry from the University of Vermont1

Involvement with Organizations

• Chair of NewYorkBIO12
• Vice Chairperson for NYBIO's Executive Committee1
• Active Board Member and Advisor to the KIF1A Foundation13
• Advisor to several early-stage biotechnology companies13

Professional Motivations

Hans Christinger is driven by two primary factors:

1. Making a meaningful difference in patients' lives
2. Building a world-class company to significantly impact those in need1

His approach involves leveraging strategic partnerships to create science-based, patient-centered companies, particularly in neurology and ophthalmology.1